Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
93 studies found for:    Open Studies | "Nephritis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Nephritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX infusions;   Other: Standard of Care
2 Recruiting Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Anifrolumab;   Drug: Placebo
3 Recruiting Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus;   Drug: Mycophenolate mofetil
4 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
5 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
6 Recruiting A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus capsules;   Drug: Cyclophosphamide injections;   Drug: Prednisone
7 Recruiting ACTHar in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: CellCept;   Drug: ACTHar gel
8 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
9 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
10 Recruiting Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)
Condition: Acute Interstitial Nephritis
Interventions: Drug: Omalizumab;   Drug: Prednisone
11 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
12 Recruiting Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
13 Recruiting A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Mizoribine (MZR);   Drug: Cyclophosphamide (CTX)
14 Recruiting Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: BI 655064 dose 1;   Drug: BI 655064 dose 2;   Drug: BI 655064 dose 3;   Drug: Placebo
15 Recruiting Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Ixazomib;   Drug: Placebo
16 Recruiting A Study to Evaluate the Safety and Efficacy of Obinutuzumab, an Antibody Targeting Certain Types of Immune Cells, in Participants With Lupus Nephritis (LN)
Condition: Lupus Nephritis
Interventions: Drug: Mycophenolate Mofetil;   Drug: Obinutuzumab;   Drug: Placebo
17 Recruiting Interest to Perform a Renal Biopsy Early in the Course of the Henoch-Schoenlein Nephritis
Condition: Henoch Schönlein Nephritis
Intervention: Other: kidney biopsy
18 Recruiting Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Condition: Systemic Lupus Erythematosus, Lupus Nephritis
Interventions: Drug: Oral prednisolone;   Drug: Rituximab;   Drug: Mycophenolate mofetil;   Drug: Methyl prednisolone
19 Not yet recruiting Iguratimod as Treatment for Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Iguratimod;   Drug: Cyclophosphamide;   Drug: Azathioprine
20 Recruiting The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: MMF-MMF;   Drug: CTX-AZA

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.